New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2014
08:47 EDTCMCSA, GSK, SNE, NFX, WFC, CHTR, TSLA, F, APC, MU, TWC, ARNA, MSFT, KW, MUR, CSCOOn the Fly: Periodicals Wrap
WSJ: Comcast's (CMCSA) Obama relationships to be tested in Time Warner Cable (TWC) deal...Charter (CHTR) likely to seek other acquisitions...Cisco's (CSCO) memory issue may be tied to Micron (MU)...REUTERS: Wells Fargo (WFC) moves back into the subprime home market...Murphy Oil (MUR) may sell about $3B of Asian assets...Brightoil interested in Anadarko (APC), Newfield (NFX) China operations...Kennedy Wilson (KW) looks to raise $1.25B from European property unit...BLOOMBERG: Ford (F) sales dominated by small SUVs...Sony (SNE) PlayStation beats Microsoft (MSFT) Xbox One sales...Tesla (TSLA) looking into cause of Toronto Model S fire...OTHER NEWS: GlaxoSmithKline (GSK) interested in Arena (ARNA), Daily Mail reports.
News For CMCSA;TWC;CHTR;CSCO;MU;WFC;MUR;APC;NFX;KW;F;SNE;MSFT;TSLA;GSK;ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
January 12, 2015
12:04 EDTGSKNovartis sees closing GSK transactions in 1H15
Novartis (NVS) says portfolio transformation is progressing "on track." Sees closing GlaxoSmithKline (GSK) transactions in 1H. In 2015, plans to execute integration of GSK oncology business, execute separation of Vaccines, ensure successful start-up of Consumer Health JV with GSK. Sees NBS to continue to deliver synergies. Comments from slides that are being presented at the JP Morgan Healthcare Conference.
10:47 EDTTSLATesla tests the $200 area, levels to watch
Subscribe for More Information
10:24 EDTARNAOptions with increasing implied volatility
Options with increasing implied volatility: TLM GREK ARNA AVP
10:15 EDTMUOptions with decreasing implied volatility
Options with decreasing implied volatility: NBIX APOL NPSP BBBY INFY JCP MU TIF
10:00 EDTCHTROn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:34 EDTTSLA, MUActive equity options trading
Subscribe for More Information
09:20 EDTFFord announces new collaboration with DowAksa for automotive carbon fiber
Subscribe for More Information
09:03 EDTMUSanDisk drops 9% after cutting Q4 revenue outlook
Shares of flash storage provider SanDisk (SNDK) are sinking after the company cut its revenue outlook for Q4 to $1.73B from $1.80B-$1.85B. It added that non-GAAP gross margin for the quarter is expected to be approximately 45% compared to the previously guided range of 47%-49%. "The lower revenue was primarily due to weaker than expected sales of retail and iNAND products," SanDisk explained. The stock is dropping 9%, or $8.40, to $88.64 in pre-market trading while peer Micron (MU) is down 3% to $32.54.
08:37 EDTGSKShire deal suggests most biotech companies in play, says JMP Securities
After Shire (SHPG) agreed to buy NPS Pharmaceuticals (NPSP), JMP Securities says the deal indicates that most biotech companies are in play, particularly those with worldwide rights to their products for well-defined patient populations. The firm expects investors to speculate all week about potential new targets in the space. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
08:05 EDTMSFTGameStop to use Microsoft Azure to stream game content, promotional materials
Subscribe for More Information
08:02 EDTARNAArena Pharmaceuticals initiates Phase 2 clinical trial evaluating ralinepag
Arena Pharmaceuticals announced the initiation of patient dosing in a Phase 2 clinical trial of ralinepag, an oral, non-prostanoid prostacyclin receptor agonist intended for the treatment of pulmonary arterial hypertension. This 22-week, randomized, double-blind and placebo-controlled Phase 2 trial will evaluate the hemodynamic and exercise capacity effects, safety and tolerability of ralinepag in up to 60 patients with PAH. During the first nine weeks of the trial, patients will be titrated to their individual tolerance level, and then sustained at this level for the remainder of the trial.
06:28 EDTCSCOCisco positioned for better than expected quarter, says Deutsche Bank
Subscribe for More Information
06:22 EDTGSKWHO approves 2 ebola vaccines to enter West Africa trials, Financial Times says
Subscribe for More Information
06:20 EDTFFord expected to debut Phoenix super car today, WSJ reports
Subscribe for More Information
06:14 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
05:52 EDTCHTRCharter initiated with an Outperform at Wells Fargo
Subscribe for More Information
January 11, 2015
19:03 EDTSNESony/ATV CEO Bandier says music business not for sale, NY Post says
Subscribe for More Information
18:54 EDTAPCCourt refuses to hear BP appeal for Deepwater Horizon liability, NY Times says
BP's (BP) request for a federal appeals court to reconsider its 2014 ruling that the company remains liable of federal penalties for the Deepwater Horizon spill in 2010 was denied, reports the New York Times. A trial will take place this month to determine BP's and Anadarko Petroleum's (APC) penalties for violation of the Clean Water Act, the Times adds. Reference Link
17:59 EDTTSLAGeneral Motors plans to launch $30K EV rival to Tesla, WSJ says
Subscribe for More Information
17:50 EDTSNESony being investigated by SEC for bribery in China, WSJ says
A report from Friday night explained that Sony is being investigated by the SEC for possible violations of the U.S. Foreign Corrupt Practices Act, specifically regarding a potential case of bribery with regards to the China release of "Resident Evil: Afterlife" in 2010, reports the Wall Street Journal, citing leaked Sony documents. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use